Michael J. Vasconcelles, M.D.
Board Member
Kura Oncology, Inc. (KURA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael J. Vasconcelles, M.D.
Michael J. Vasconcelles, M.D. is recorded as Board Member at Kura Oncology, Inc. (KURA). Kura Oncology, Inc. reported in an 8-K filed September 17, 2024 that Michael J. Vasconcelles, M.D. was appointed Class III director, effective September 13, 2024.
“On September 13, 2024, the Board of Directors (the "Board") of Kura Oncology, Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Michael J. Vasconcelles, M.D. as (i) a Class III director of the Company, with a term of office expiring at the 2026 annual meeting of stockholders and (ii) a member of the Compensation Committee of the Board (the "Compensation Committee").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kura Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Troy Wilson CEO
- Jennifer Fulk CFO
- Marc Grasso CFO
- Troy E. Wilson, Ph.D., J.D. CFO, Board Member
- Kathleen Ford COO
- Thomas Doyle Chief Accounting Officer
- Carol A. Schafer Board Member
- Carol Schafer Board Member
- Diane Parks Board Member
- Faheem Hasnain Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.